Navigation Links
BioClinica Releases Integrated Medical Image Management Solution
Date:4/16/2013

NEWTOWN, Pa., April 16, 2013 /PRNewswire/ -- BioClinica®, Inc., a global provider of clinical trial management services, announced today the newest release of WebSend, the company's industry-leading medical image submission technology for clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20130403/PH87647LOGO)

BioClinica WebSend is an electronic data transfer solution that offers significant value over other methods to collect and manage medical images for clinical trials. Investigator sites use WebSend to securely transmit medical images for clinical trials over the internet. Pharmaceutical clinical trial sponsors prefer WebSend to outdated alternatives and courier services because it improves the quality of their trial data, makes clinical imaging data immediately available for review, and reduces costs of conducting an imaging-based clinical trial.

The newest version of WebSend offers many capabilities that improve data quality and reduce cost:

  • Protected Health Information (both meta-data and pixel data) is removed prior to image submission
  • Protocol deviations are fully documented before images leave the investigator site.
  • Both DICOM and non-DICOM image data is supported through one system
  • Browser-based DICOM viewer for both web-submitted and couriered images
  • 100% integration with BioPACS, BioClinica's image management system, which eliminates manual data entry and ensures data quality

"Electronic image submission is the best way to ensure data quality and reduce the cost of imaging-based clinical trials," said Mark Weinstein , CEO of BioClinica, "and WebSend is the clear choice to meet these goals." "When an image is uploaded via WebSend, it automatically becomes part of BioClinica's integrated image management and independent review system. There are no manual steps, data entries, or transfers required. Best of all, sponsors have immediate access to their images through BioClinica's secure web portal." 

In addition to advantages for trial sponsors, WebSend also makes participation in imaging-based clinical trials easier for investigator sites. WebSend provides a single point of contact for sites with an easy-to-use interface for uploading images. It features a "To-Do" task list that leads users through the upload process and helps reduces errors. Also, WebSend utilizes advanced technology to speed up transfer times and allow multiple images to be uploaded simultaneously.

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. A 2013 merger with CoreLab Partners has created a new standard in imaging core lab services including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies,  Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3300 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

 


'/>"/>
SOURCE BioClinica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
2. HCCS Releases ICD-10 Countdown Clock With Integrated CMS Twitter Tweets
3. eCareSoft Releases eCS Cirrus™
4. AtheroNova Releases 2011 Financial Results
5. Atlanta LASIK Surgeon Dr. Ashraf Releases YouTube Videos Featuring Patient Testimonials and Discussion of Common Eye Treatments
6. ILVO-T&V Belgium Releases Validation Report of the Charm Sciences Beta-lactam and Tetracycline 2-minute Test for Raw Commingled Milk
7. ISPE Releases New Guidance for Designing and Constructing Packaging, Labeling and Warehousing Facilities
8. Happtique Releases Draft App Certification Program Standards For Public Comment
9. ClearCanvas Releases New Workstation Products Designed to Assist With Image Sharing
10. OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
11. Weight Loss: Natural Way To Lose More Weight Than With Diet & Exercise Alone - Consumer Reporter Releases A New Video
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... http://www.Financialbuzz.com - According ... causes of death worldwide. There were 8.2 million cancer ... related deaths increased gradually over time, the death rates ... various cancers continues to drive demand of biological therapies ... Market Insights, Inc. cancer biological therapy market size was USD ...
(Date:1/19/2017)... , Jan 19, 2017 Research and ... by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis ... ... forecasts that the global market is projected to reach $15,737 million ... 13% from 2016 to 2022. Omic technologies segment ...
(Date:1/19/2017)... LOUISVILLE, Ky. and HOUSTON ... Prenatal Inc. ("NX Prenatal") today announced the formation ... brings together leading clinicians and industry veterans who ... the company as it accelerates development of its ... positioned to provide medical, clinical and strategic guidance ...
(Date:1/19/2017)... Research and Markets ... announced the addition of the "Implantable Biomaterials Market ... report to their offering. Report Highlights: ... analysis on current and future market trends to identify the investment opportunities ... the base numbers Key market trends across the business ...
Breaking Biology Technology:
(Date:1/12/2017)...  New research undertaken by Fit Small Business ... participants were simply asked which office technology had they not ... standard issue.  Insights on what will be key ... futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):